On July 14, 2015, BG Medicine, Inc. closed the transaction. The company issued 1,176,262 series A preferred shares at a price of $1.7003 per share for $1,999,998.29. The company has agreed to extend the period of time following its 2015 annual meeting of stockholders for the second closing to occur until July 14, 2015.

The investor converted the note issued in the first tranche plus accrued but unpaid interest into a total of 1,474,443 series A preferred shares. AGTC Fund L.P. invested for a total of $308,487.65 in principal amount of notes and 183,971 shares, AGTC Advisors Fund, L.P. invested for a total of $22,726.86 in principal amount of notes and 13,553 shares, and Flagship Ventures Fund 2007, L.P. invested for a total of $308,487.65 in principal amount of notes and 183,971 shares.